Omilux 20 mg (Capsule (Enteric Coated))
Unit Price: ৳ 5.00 (100's pack: ৳ 500.00)
Medicine Details
Category | Details |
---|---|
Generic | Omeprazole |
Company | Quality pharmaceuticals ltd |
Indications
- Gastric and duodenal ulcer
- NSAID-associated duodenal and gastric ulcer
- As prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
- Gastro-esophageal reflux disease
- Long-term management of acid reflux disease
- Acid-related dyspepsia
- Severe ulcerating reflux esophagitis
- Prophylaxis of acid aspiration during general anesthesia
- Zollinger-Ellison syndrome
- Helicobacter pylori-induced peptic ulcer
Pharmacology
- Inhibitor of gastric acid secretion
- Blocks hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system
- Onset of antisecretory effect within one hour
- Maximum effect occurring within two hours
- Inhibition of secretion lasts up to 72 hours
- Gradual return of secretory activity over 3 to 5 days post discontinuation
Dosage
- 20 mg once daily for benign gastric and duodenal ulcer
- 20 mg once daily for NSAID-associated duodenal or gastric ulcer
- 20 mg once daily for gastro-esophageal reflux disease
- 10-20 mg daily for long-term management of acid reflux disease
- 10-20 mg once daily for acid-related dyspepsia
- 40 mg on the preceding evening, then 40 mg 2-6 hours before surgery for prophylaxis of acid aspiration
Administration
- For intravenous administration only
- Slow intravenous injection required
- Intravenous infusion over a period of 20-30 minutes
- Reconstituted solution should be used within specified time
- Cannot be mixed or co-administered with other drugs in the same infusion set
Interaction
- Decreased intragastric acidity affecting the absorption of ketoconazole
- Metabolized in the liver through cytochrome P450
- Potential delay in elimination of diazepam, phenytoin, and warfarin
- Monitoring recommended for patients receiving warfarin or phenytoin
- Plasma concentrations increased during concomitant administration with certain drugs
- No evidence of interaction with specific medications
Contraindications
- Known hypersensitivity to omeprazole
- Suspicion of gastric ulcer without excluding malignancy
Side Effects
- Mild and reversible adverse reactions
- Skin rash, urticaria, and pruritus reported
- Photosensitivity, bullous eruption, and erythema multiforme in isolated cases
- Diarrhea and headache, which may be severe enough to require discontinuation of therapy
- Other gastrointestinal reactions such as constipation, nausea/vomiting, and abdominal pain
- Dizziness, light headedness, and feeling faint reported
Pregnancy & Lactation
- No adverse effects on pregnancy or fetal health reported
- Safe for use during pregnancy
- No information available on passage into breast milk or effects on the neonate
- Breastfeeding should be discontinued if essential
Precautions & Warnings
- Avoid concomitant use with clopidogrel
- Potential association with increased risk for osteoporosis-related fractures
- Atrophic gastritis noted occasionally with long-term use
- Concomitant use with methotrexate may lead to methotrexate toxicities
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Related Brands
- Pear 20 mg (Capsule (Enteric Coated)) - prime-pharmaceuticals-ltd
- Presectil 20 mg (Capsule (Enteric Coated)) - premier-pharmaceuticals-ltd
- Eupi 40 mg (Capsule (Enteric Coated)) - pharmasia-limited
- Ranzo 20 mg (Capsule (Enteric Coated)) - oyster-pharmaceuticals-ltd
- Orpra 40 mg (Capsule (Enteric Coated)) - orbit-pharmaceuticals-ltd